[Current aspects of lymphangioleiomyomatosis]

Area of Science:

• Pulmonary Medicine
• Oncology
• Genetics

Background:

• Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease causing cystic destruction due to abnormal smooth muscle cell proliferation.
• HMB45, a marker for melanocyte lineage cells, also labels LAM and renal angiomyolipoma cells, suggesting a common antigen like gp-100.
• Genetic loci TSC1 and TSC2 are implicated in Bourneville tuberous sclerosis (BTS), with TSC2 potentially involved in pulmonary LAM pathogenesis.

Purpose of the Study:

• To explore the potential link between LAM and BTS, considering them as different phenotypic expressions of the same disease.
• To investigate the hormone-dependence theory of LAM based on clinical observations, particularly female predominance during reproductive years.
• To review recent advancements in LAM diagnosis and understanding disease progression.

Main Methods:

• Review of clinical and histological features of LAM and BTS.
• Analysis of epidemiological data from the GERM"O"P registry in France.
• Evaluation of diagnostic advancements, including HMB45 immunolabeling and imaging techniques.

Main Results:

• LAM and BTS share clinical and histological similarities, suggesting a potential unified disease spectrum.
• HMB45 immunolabeling enhances diagnostic sensitivity in transbronchial biopsies.
• LAM exhibits variable progression rates, from rapidly fatal to very slow evolution, with lung transplantation as a critical treatment for severe cases.

Conclusions:

• LAM and BTS may represent distinct phenotypic manifestations of a single underlying disease.
• Further research is needed to validate the hormone-dependence theory due to the lack of in vitro or animal models.
• Early diagnosis through improved imaging and HMB45 staining, alongside understanding disease heterogeneity, is crucial for patient management.